WO2002064246A1 - Verfahren zur herstellung blauer mikrokapseln - Google Patents

Verfahren zur herstellung blauer mikrokapseln Download PDF

Info

Publication number
WO2002064246A1
WO2002064246A1 PCT/EP2002/000855 EP0200855W WO02064246A1 WO 2002064246 A1 WO2002064246 A1 WO 2002064246A1 EP 0200855 W EP0200855 W EP 0200855W WO 02064246 A1 WO02064246 A1 WO 02064246A1
Authority
WO
WIPO (PCT)
Prior art keywords
oil
capsules
blue
microcapsules
mixture
Prior art date
Application number
PCT/EP2002/000855
Other languages
German (de)
English (en)
French (fr)
Inventor
Rita Lages
Frank Aickele
Hubert Loges
Arnold Machinek
Original Assignee
Symrise Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symrise Gmbh & Co. Kg filed Critical Symrise Gmbh & Co. Kg
Priority to EP02708317A priority Critical patent/EP1363731B1/de
Priority to AT02708317T priority patent/ATE306315T1/de
Priority to BRPI0207119-3A priority patent/BR0207119B1/pt
Priority to DE50204524T priority patent/DE50204524D1/de
Priority to JP2002564034A priority patent/JP2004526558A/ja
Publication of WO2002064246A1 publication Critical patent/WO2002064246A1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/06Making microcapsules or microballoons by phase separation
    • B01J13/08Simple coacervation, i.e. addition of highly hydrophilic material
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0097Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42Colour properties
    • A61K2800/43Pigments; Dyes

Definitions

  • the invention relates to a process for the production of uniformly colored blue microcapsules using oil-soluble dyes. These capsules are mainly used in the cosmetic industry and oral hygiene.
  • the present invention describes the encapsulation of a mixture of an oil-soluble material and a dye, the capsules obtained having a blue to dark blue color.
  • the preferred encapsulation method is here
  • the capsules thus obtained which have a colorless, transparent shell and a blue core, are preferably incorporated into products in the field of oral hygiene.
  • microcapsules with a transparent shell containing an oil and a dye or a dye suspension
  • the oily material mainly serves as a solvent or vehicle for the dye.
  • EP-A-711 544 describes a toothpaste using capsules containing
  • the capsules have an average size of 0.3 to 3 mm.
  • WO 99/59535 A special form of encapsulation for oral hygiene products is described in WO 99/59535, in which the focus is on the aspects of the stability of the capsules in the presence of surface-active substances and foaming.
  • WO 00/48560 deals with the encapsulation of a mixture of a liquid oil and a copper chlorophyll extract. These green microcapsules are preferably used in oral hygiene products. Typical oils are sunflower oil or paraffin oil.
  • microcapsules are usually produced by means of coacervation and the oil core is colored, if necessary. There are basically two options for producing blue capsules.
  • the capsule is coated with a water-soluble dye, the capsule becomes discolored due to so-called bleeding of the color or due to instability of the color in the preparation or formulation of the application product.
  • oil-soluble dyes or pigment dyes come into consideration for this type of coloring.
  • pigment dyes the problem of sedimentation occurs very often, i.e. that the dye is not homogeneously distributed in the capsule and optically the
  • the invention therefore relates to a method for producing blue
  • Microcapsules by encapsulating a mixture of a lipophilic core material and an oil-soluble dye, characterized in that D&C Green No. 6 or guaiazulene or a mixture of these two dyes is used as the dye.
  • guaiazulene (7-isopropyl-l, 4-dimethylazulene) has proven itself, on the other hand D&C Green No. 6 (1,4-bis (4-methylphenyl) amino) -9,10-anthracendione; 1,4-p-toluidinoanthraquinone; CI. 61565).
  • D&C Green No. 6 (1,4-bis (4-methylphenyl) amino) -9,10-anthracendione; 1,4-p-toluidinoanthraquinone; CI. 61565).
  • the latter is particularly surprising since it is listed as a green oil-soluble dye in the dye lists. Both substances are commercially available dyes.
  • the dyes are in 0.02% to 2%, preferably in 0.05% to 1.5%, particularly preferably in 0.1% to 1% and very particularly preferably in 0 , 1% to 0.5% added to the core material.
  • the figures are percentages by weight and relate to the amount used
  • Encapsulation materials that are typically used include: Cyclodextrins, gum arabic, gelatin, casein, albumin, fibrinogen, xanthan gum, soluble peptides, sodium alginate, carboxymethyl cellulose, polyvinylpyrrolidone and other natural or synthetic polymeric materials.
  • the encapsulation materials are preferably additionally crosslinked.
  • the crosslinking can be inherent to the encapsulation material or can be brought about by adding so-called crosslinking agents, such as, for example, glutaraldehyde.
  • the encapsulation can be carried out according to methods known per se and described in the literature. Coacervation is preferred in the method according to the invention.
  • Crosslinking with a crosslinking agent, preferably glutardialdehyde, in order to achieve the desired hardness of the capsules.
  • a crosslinking agent preferably glutardialdehyde
  • the manufacturing process can be carried out as follows, for example:
  • the mostly liquid core material is mixed with the dye.
  • This mixture is then introduced into an aqueous solution of the shell material, preferably containing gelatin, at 40-60 °.
  • another casing material can be added, preferably gum arabic.
  • a stabilizer or preservative can be added to the aqueous solution; potassium sorbate is preferred.
  • This emulsion is adjusted to a pH in the range from 3.8 to 4.8, a pH range from 4.0 to 4.5 is preferred.
  • the coacervates form, i.e. the dye-containing liquid core material is surrounded by a film of shell material and water, the microcapsules being formed. After cooling, usually to temperatures below 15 ° C, can
  • a crosslinker preferably glutardialdehyde, is added to harden the shell.
  • the order of processing can be modified in such a way that the dye-containing core material is added to an aqueous solution of gelatin and gum arabic and finally the pH is adjusted.
  • the processing temperatures are lower, usually 30 to 45 ° C.
  • the capsules are in the form of a slurry that can be used as such. It can, depending on your needs and
  • Thickeners preferably carboxymethyl cellulose, preservatives and stabilizers, for example potassium sorbate and citrates, can be added to the slurry. If necessary, the slurry can also be subjected to drying, after which the microcapsules are in flowable form.
  • the microcapsules have a transparent or translucent capsule shell and contain a blue liquid or a blue low-melting core material.
  • the capsules produced according to the invention are thus clearly visible in the application product, for example an oral hygiene product.
  • properties such as hardness, size, wall thickness, color depth or stability of the capsules can be significantly influenced.
  • the hardness of the capsules can be adjusted by the method according to the invention in such a way that the capsules are neither too hard to survive the cleaning process nor too soft to be destroyed during the manufacturing process of the oral hygiene product become. In such a case, the aim is rather that the capsules are gradually destroyed over the entire period of the cleaning process and so one controlled release of the lipophilic material contained in the capsules can take place.
  • the particle size of the blue capsules produced by the process according to the invention is typically in the range from 0.3 to 2.5 mm, preferably in the range from 0.5 to 1.8 mm and particularly preferably in the range from 0.8 to 1.2 mm ,
  • the particle size can be measured using conventional methods, such as, for example, by sieving or microscopy.
  • the oil-soluble core material to be encapsulated according to the invention can consist of a single substance or a mixture of substances. Some of the following are examples of suitable core materials.
  • Proteins Proteins, keratin, collagen, casein, lecithin, sorbitol, antioxidants, phenol derivatives, antimicrobial agents, anti-inflammatory substances, anti-caries
  • Substances vitamins, enzymes, plant extracts, preservatives, pH regulators, sweeteners, starches, flavors and aromas.
  • ethereal oils and extracts, tinctures and balms such as, for example, anise oil, is particularly suitable as core material in the sense of the invention.
  • substances with a cooling, refreshing effect in the mouth, throat or nose are particularly suitable as core material.
  • Menthol, menthone, carboxamides, methacetals, menthol carbonates, menthol succinates, 1,8-cineol (eucalyptol), carvone, alpha-terpineol, thyol, methyl salicylate, 2'-hydroxypropiophenone may be mentioned here, for example.
  • the optically active compounds can be used in enantiomerically pure form or as any mixtures of the two enantiomers.
  • capsules according to the invention in cosmetics and oral hygiene: creams, gels, foams, dispersions, chewing gums, lozenges and candies.
  • the area of application of dental care products is particularly preferred, in particular that of toothpastes, toothpastes, tooth gels.
  • the capsules are added to the oral hygiene application in 0.05% to 5%, preferably in 0.2% to 3% and particularly preferably in 0.5% to 1.5%.
  • the data are percentages by weight and relate to the finished product formulation or the overall recipe.
  • a mixture of peppermint oil and 0.25% guaiazulen was made. This was added to an aqueous gelatin solution at 50 ° C. An aqueous solution of gum arabic was then added to this emulsion. The pH of the mixture was adjusted to 4.5 with stirring with aqueous acetic acid solution. The mixture was slowly cooled to room temperature and then glutardialdehyde was added. The supernatant solution was decanted off and the microcapsules were washed several times with water. The capsules thus produced had a diameter of 0.5 to 1.4 mm. These microcapsules had a transparent shell and a blue colored core material.
  • Example 3 Example 3:
  • a transparent tooth gel was produced with the following basic recipe, into which the blue capsules produced using different staining methods or with different dyes were incorporated.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicinal Preparation (AREA)
PCT/EP2002/000855 2001-02-09 2002-01-28 Verfahren zur herstellung blauer mikrokapseln WO2002064246A1 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP02708317A EP1363731B1 (de) 2001-02-09 2002-01-28 Verfahren zur herstellung blauer mikrokapseln
AT02708317T ATE306315T1 (de) 2001-02-09 2002-01-28 Verfahren zur herstellung blauer mikrokapseln
BRPI0207119-3A BR0207119B1 (pt) 2001-02-09 2002-01-28 processo para produzir microcápsulas azuis, e uso das mesmas.
DE50204524T DE50204524D1 (de) 2001-02-09 2002-01-28 Verfahren zur herstellung blauer mikrokapseln
JP2002564034A JP2004526558A (ja) 2001-02-09 2002-01-28 青色マイクロカプセルの製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10106446.2 2001-02-09
DE10106446A DE10106446A1 (de) 2001-02-09 2001-02-09 Verfahren zur Herstellung blauer Mikrokapseln

Publications (1)

Publication Number Publication Date
WO2002064246A1 true WO2002064246A1 (de) 2002-08-22

Family

ID=7673748

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/000855 WO2002064246A1 (de) 2001-02-09 2002-01-28 Verfahren zur herstellung blauer mikrokapseln

Country Status (8)

Country Link
US (1) US6506368B2 (pt)
EP (1) EP1363731B1 (pt)
JP (1) JP2004526558A (pt)
AT (1) ATE306315T1 (pt)
BR (1) BR0207119B1 (pt)
DE (2) DE10106446A1 (pt)
ES (1) ES2249560T3 (pt)
WO (1) WO2002064246A1 (pt)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006077394A2 (en) * 2005-01-19 2006-07-27 The Central Science Laboratory (Csl) Representing The Secretary Of State For Environment, Food And Rural Affairs Formulation
WO2009112378A2 (de) * 2008-03-03 2009-09-17 Basf Se Mikrokapseln, ihre herstellung und verwendung
EP2865372A1 (de) * 2013-10-22 2015-04-29 Symrise AG Wirkstoffkapseln
WO2015158635A1 (de) * 2014-04-14 2015-10-22 Symrise Ag Kapseln mit hoher wirkstoffbeladung

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05001299A (es) * 2002-08-02 2005-04-28 Gillette Co Composiciones claras para cuidado personal que contienen capsulas visibles.
US7147466B1 (en) * 2003-10-24 2006-12-12 Dentsply International, Inc. Pressure indicator gel system and method therefore
CN1949986B (zh) * 2004-03-04 2010-09-22 奎斯特国际公司 颗粒调味料组合物
CA2561914C (en) * 2004-04-05 2013-09-10 Pfizer Products Inc. Microfluidized oil-in-water emulsions and vaccine compositions
GB0510498D0 (en) * 2005-05-23 2005-06-29 Glaxo Group Ltd Microcapsule composition
WO2007009023A2 (en) * 2005-07-13 2007-01-18 Engineered Release Systems, Inc. Chemically cross-linked elastomeric microcapsules
US20080292692A1 (en) * 2007-05-21 2008-11-27 Shira Pilch Impermeable Capsules
US20110151064A1 (en) * 2009-12-21 2011-06-23 Conopco, Inc., D/B/A Unilever Particulate frozen confection
EP2347659B1 (en) * 2010-01-22 2012-08-22 Unilever PLC Process for producing frozen particles
DE102013210188A1 (de) * 2013-05-31 2014-12-04 Beiersdorf Ag Naturkosmetik-konforme Mehr-Phasen-Zubereitungen enthaltend Guaiazulen
WO2015138319A1 (en) * 2014-03-10 2015-09-17 Isp Investments Inc. Oral care compositions comprising microcapsules with effective breakage characteristics
CA3072927C (en) * 2015-04-09 2020-11-17 Saudi Arabian Oil Company Encapsulated nanocompositions for increasing hydrocarbon recovery
ES2808657T3 (es) * 2015-09-03 2021-03-01 Oreal Gel acuoso para el cuidado y/o maquillaje de materiales de queratina que comprende microcápsulas que encapsulan una dispersión aceitosa de al menos un agente reflectante
JP2023538276A (ja) * 2020-08-06 2023-09-07 シムライズ アーゲー マイクロカプセルの調製プロセス

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1381444A (en) * 1972-08-04 1975-01-22 Blendax Werke Schneider Co Toothpaste
US3864275A (en) * 1963-10-21 1975-02-04 Pilot Pen Co Ltd Process for enveloping fine drops of dispersed liquids
US3893933A (en) * 1973-02-23 1975-07-08 Xerox Corp Process for producing encapsulated toner composition
US4459277A (en) * 1980-10-07 1984-07-10 Kosti Carl M Plaque disclosing dentifrice compositions with solid microcapsules of dye

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341466A (en) 1966-10-31 1967-09-12 Brynko Carl Process for making capsules
US3957964A (en) * 1974-01-30 1976-05-18 Colgate-Palmolive Company Dentifrice containing encapsulated flavoring
US4071614A (en) * 1975-06-03 1978-01-31 Colgate Palmolive Company Dentifrice containing encapsulated flavoring
US4348378A (en) * 1979-08-09 1982-09-07 Kosti Carl M Plaque disclosing dentifrice compositions with semi-solid microcapsules of dye
US5232769A (en) * 1989-08-01 1993-08-03 Kanebo, Ltd. Microcapsule, treating liquids containing the same, and textile structure having microcapsules adhering thereto
DE4040907A1 (de) * 1990-12-20 1992-06-25 Basf Ag Verdoppelte azulenquadratsaeurefarbstoffe, deren zwischenprodukte sowie optisches aufzeichnungsmedium
US5278693A (en) * 1992-01-13 1994-01-11 Gentex Corporation Tinted solution-phase electrochromic devices
US5237769A (en) * 1992-06-29 1993-08-24 Navarro Kenneth D Fishing rod balance device
US5411802A (en) * 1993-10-29 1995-05-02 Minnesota Mining And Manufacturing Company Colorant compositions and processes
TW412425B (en) 1994-10-18 2000-11-21 Kao Corp Dentifrice composition having capsule particles
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
AU4143999A (en) 1998-05-15 1999-12-06 Unilever Plc Oral composition comprising capsules
EP1152739A1 (en) * 1999-02-15 2001-11-14 Unilever N.V. Encapsulation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864275A (en) * 1963-10-21 1975-02-04 Pilot Pen Co Ltd Process for enveloping fine drops of dispersed liquids
GB1381444A (en) * 1972-08-04 1975-01-22 Blendax Werke Schneider Co Toothpaste
US3893933A (en) * 1973-02-23 1975-07-08 Xerox Corp Process for producing encapsulated toner composition
US4459277A (en) * 1980-10-07 1984-07-10 Kosti Carl M Plaque disclosing dentifrice compositions with solid microcapsules of dye

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006077394A2 (en) * 2005-01-19 2006-07-27 The Central Science Laboratory (Csl) Representing The Secretary Of State For Environment, Food And Rural Affairs Formulation
WO2006077394A3 (en) * 2005-01-19 2006-11-23 Central Science Lab Csl Repres Formulation
AU2006207365B2 (en) * 2005-01-19 2011-10-13 The Secretary Of State For Environment, Food And Rural Affairs Formulation
WO2009112378A2 (de) * 2008-03-03 2009-09-17 Basf Se Mikrokapseln, ihre herstellung und verwendung
WO2009112378A3 (de) * 2008-03-03 2010-05-06 Basf Se Mikrokapseln, ihre herstellung und verwendung
US8349452B2 (en) 2008-03-03 2013-01-08 Basf Se Microcapsules, their preparation and use
EP2865372A1 (de) * 2013-10-22 2015-04-29 Symrise AG Wirkstoffkapseln
WO2015059062A1 (en) * 2013-10-22 2015-04-30 Symrise Ag Active ingredient capsules
US10299996B2 (en) 2013-10-22 2019-05-28 Symrise Ag Active ingredient capsules
WO2015158635A1 (de) * 2014-04-14 2015-10-22 Symrise Ag Kapseln mit hoher wirkstoffbeladung
US11471385B2 (en) 2014-04-14 2022-10-18 Symrise Ag Capsules with a high active ingredient content

Also Published As

Publication number Publication date
JP2004526558A (ja) 2004-09-02
BR0207119B1 (pt) 2012-06-26
DE10106446A1 (de) 2002-10-10
ES2249560T3 (es) 2006-04-01
DE50204524D1 (de) 2006-02-23
EP1363731A1 (de) 2003-11-26
US20020159957A1 (en) 2002-10-31
EP1363731B1 (de) 2005-10-12
BR0207119A (pt) 2004-02-10
ATE306315T1 (de) 2005-10-15
US6506368B2 (en) 2003-01-14

Similar Documents

Publication Publication Date Title
EP1363731B1 (de) Verfahren zur herstellung blauer mikrokapseln
DE19860754B4 (de) Kosmetische Zubereitung
US3947571A (en) Lipstick containing microencapsulated oils
DE69915798T2 (de) Erweichende zusammensetzung basierend auf jojoba ester
AT400806B (de) Puder, verfahren zur herstellung eines kosmetischen puders, sowie kosmetisches mittel zur färbung der haare oder zum schminken der haut
DE69926862T2 (de) Kosmetische oder dermo-pharmazeutische zusammensetzung in form von hydrophoben perlen und herstellungsverfahren
DE1103521B (de) Mittel zum Braeunen der Haut
DE60120284T2 (de) Verwendung von 4',5,7-Trihydroxyflavylium als Hautfärbemittel
EP1003463B1 (de) Kosmetische zusammensetzungen mit agglomerierten substraten
WO2005094760A1 (de) Kosmetische zubereitung
EP2066310B1 (de) Emulsionen enthaltend gummi arabicum
AT393450B (de) Haarfaerbemittel
EP0306853B1 (de) Kosmetisches Präparat mit germiziden Eigenschaften
DE3204636A1 (de) Schminke
DE3344438C2 (pt)
EP0622070B1 (de) Hautfärbende Pulvermischung
DE60109236T2 (de) Hautfärbemittel enthaltend Dihydroxyaceton und einen in Position 3 unsubstituierte Flavylium-Salz Verbindung
DE2238332A1 (de) Zahnpasta
DE3244452C2 (pt)
DE3526546A1 (de) Lichtbestaendige opakisierte gelatinekapseln und verfahren zur herstellung derselben
DE10042576B4 (de) Kosmetischer Basiskomplex und dessen Verwendung
EP3727599A1 (de) Mittel zum färben von keratinfasern enthaltend eine kombination aus einem p-phenylenderivat und 2,7-naphthalindiol sowie dessen verwendung zur reduzierung des gelbstichs in einer frisur
JPS60109512A (ja) 界面活性剤組成物
EP2142015A2 (de) Emulsionsvorkonzentrate sowie micellare formulierungen enthaltend wurzelharz
EP2151231B1 (de) Kosmetische Formulierung

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 754/MUMNP/2003

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2002564034

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002708317

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002708317

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2002708317

Country of ref document: EP